C07K 14/08
Rna viruses
Official title: RNA viruses
C07K14/08 (Rna viruses) appears on 645 US grants and 1,129 published applications in this corpus.
Search patents in C07K- Granted patents
- 645
- Published applications
- 1,129
- Assignees
- 612
- Inventors
- 2,281
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 1 | 2 |
| 2005 | 0 | 11 |
| 2006 | 1 | 2 |
| 2007 | 1 | 2 |
| 2008 | 1 | 5 |
| 2009 | 8 | 7 |
| 2010 | 3 | 6 |
| 2011 | 5 | 14 |
| 2012 | 4 | 11 |
| 2013 | 9 | 55 |
| 2014 | 18 | 21 |
| 2015 | 25 | 32 |
| 2016 | 22 | 45 |
| 2017 | 23 | 36 |
| 2018 | 45 | 74 |
| 2019 | 55 | 109 |
| 2020 | 48 | 72 |
| 2021 | 70 | 133 |
| 2022 | 75 | 106 |
| 2023 | 60 | 131 |
| 2024 | 63 | 131 |
| 2025 | 71 | 59 |
| 2026 | 37 | 63 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07K 14/15Retroviridae192
- C07K 14/18Togaviridae124
- C07K 14/11Orthomyxoviridae108
- C07K 14/165Coronaviridae99
- C07K 14/115Paramyxoviridae46
- C07K 14/085Picornaviridae17
- C07K 14/14Reoviridae10
- C07K 14/145Rhabdoviridae10
All 10 subgroupsShow fewer
Recent patents
- Mutant influenza B/Victoria lineage virus hemagglutinin proteins6 Oct 2026US 12,752,001 B2ModernaTX, Inc.
- Antiviral structurally-stabilized Ebolavirus peptides and uses thereof6 Oct 2026US 12,753,208 B2Dana-Farber Cancer Institute, Inc.
- Method for preparing and certifying novel coronavirus nucleocapsid protein15 Sep 2026US 12,735,460 B2National Institute of Metrology, China
- Antigen for 2019 novel Coronavirus and detection use thereof15 Sep 2026US 12,736,543 B2Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
- Vaccine using M2/BM2-deficient influenza vectors8 Sep 2026US 12,728,160 B2FluGen, Inc.
- Dengue virus serotype-specific modulation of t cell responses8 Oct 2026US 2026/0306621 A1The United States Government as represented by the Department of Veterans Affairs
- Improved expression of surface-displayed antigens1 Oct 2026US 2026/0295030 A1Inprother Aps
- Hiv vaccine24 Sep 2026US 2026/0284176 A1
- Peptide compounds to regulate the complement system24 Sep 2026US 2026/0285907 A1Realta Holdings, LLC
- Immunogenic trimers17 Sep 2026US 2026/0273042 A1International AIDS Vaccine Initiative
Most cited
By later US patents
- High potency immunogenic zika virus compositions92US 10,273,269 B2ModernaTX, Inc. · 2019
- Zika RNA vaccines85US 10,449,244 B2ModernaTX, Inc. · 2019
- MERS coronavirus vaccine31US 11,141,476 B2CureVac AG · 2021
- Influenza hemagglutinin and neuraminidase variants31US 8,574,593 B2MedImmune, LLC · 2013
- Avirulent, immunogenic flavivirus chimeras29US 7,094,411 B2The United States of America as represented by the Department of Health and Human Services · 2006